Get startedLog in
    Picture of Alamar Biosciences logo

    ALMR — Alamar Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut

    Picture of Alamar Biosciences logoAlamar Biosciences
    08/05/2026 16:54
    May 8 (Reuters) - Odyssey Therapeutics ODTX.O shares rose 11.1% in its Nasdaq debut on Friday, giving the biopharmaceutical firm a valuation of $899.9 million.

 (Reporting by Prakhar Srivastava in Bengaluru; Editing by Vijay Kishore)

 ((Prakhar.srivastava2@thomsonreuters.com;))

    Recent news on Alamar Biosciences

    See all news